Statistics

Total Visits

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study32

Select a period of time:

Number of views in the range

Views
Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study22

Views

Views
December 20240
January 20251
February 20251
March 202515
April 20252
May 20253
June 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United Kingdom3
United States2
Germany1
Spain1
 

Top cities views

Views
Council Bluffs1
Nuremberg1